Article

Wwraltechwire.com on 2023-05-03 14:56

Alzheimer's drug candidate from Eli Lilly delivers 'the kind of efficacy that's never been seen before'

Based on the results, in people with early symptomatic Alzheimer's disease, Lilly says it plans to file for approval from the US Food and Drug ...

Related news

BEli Lilly Will Unveil Alzheimer's Drug Data Next Week. What to Watch.barrons.com
Phase 2
BEli Lilly Makes a Case For Its Alzheimer's Drug as Shares Drop barrons.com
Phase 2
BEli Lilly May Be a Big Winner From FDA's Alzheimer's Decision4 min barrons.com
Mizuho-machi
BEli Lilly Offers More Positive Data on Its Alzheimer's Drug. What Investors Need to Know.barrons.com
Phase 2
Eli Lilly: Experimental Alzheimer's drug works The Salt Lake Tribune
Amsterdam , Mayo Clinic , Washington , Indianapolis
Eli Lilly says experimental drug slows Alzheimer's worsening timesfreepress.com
Indianapolis
BEli Lilly Executives Enthusiastic About Alzheimer's Drug, Analyst Says barrons.com
Phase 2
Eli Lilly: Experimental Alzheimer's drug shows some benefit dothaneagle.com
Amsterdam , Mayo Clinic , Indianapolis
MEli Lilly and AstraZeneca to co-develop Alzheimer's Disease treatment marketwatch.com
Eli Lilly michronicleonline.com
Puerto Rico
BEli Lilly Is Asking the FDA to Approve Its Alzheimer's Therapy4 min read barrons.com
BEli Lilly Stock Falls After Alzheimer's Drug Results Disappoint Wall Street barrons.com
Wall Street
BEli Lilly Stock Soared on Alzheimer's Hopes. Now Wall Street Has Doubts.3 min read barrons.com
Wall Street
Experimental Alzheimer's drug slows cognitive declines in large trial, drugmaker Eli Lilly says post-gazette.com
MEli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment marketwatch.com
Phase 1
PAmgen to team with Eli Lilly on COVID treatment pacbiztimes.com
Indianapolis , Thousand Oaks
Eli Lilly Exploring Elanco Spinoff wsj.com
Eli Lilly CEO to Retire wsj.com